# A Randomised, Double-blind, Placebo-controlled Phase IIb Trial to Test FLU-v Vaccine

> **NCT02962908** · PHASE2 · COMPLETED · sponsor: **PepTcell Limited** · enrollment: 175 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** FLU-v
- **BIOLOGICAL:** adjuvanted FLU-v
- **BIOLOGICAL:** Saline
- **BIOLOGICAL:** Adjuvanted placebo

## Key facts

- **NCT ID:** NCT02962908
- **Lead sponsor:** PepTcell Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-08
- **Primary completion:** 2017-07-18
- **Final completion:** 2017-07-18
- **Target enrollment:** 175 (ACTUAL)
- **Last updated:** 2020-09-16

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02962908

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02962908, "A Randomised, Double-blind, Placebo-controlled Phase IIb Trial to Test FLU-v Vaccine". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02962908. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*